MHN statement regarding HR 3, the House’s drug pricing package

Washington, DC (November 13, 2019) - Men’s Health Network (MHN), a national non-profit organization whose mission is to raise awareness of men’s health issues, released the following statement regarding HR 3, the House’s drug pricing package: While it is encouraging that legislators are working to lower health care costs, it’s imperative that the means of achieving these goals also maintains the quality of care patients need. Unfortunately, that is not the case of the proposals included in Speaker Pelosi’s recent drug pricing package. Efforts to redesign the Part D prescription drug benefit will undermine Medicare’s competitive marketplace, which is instrumental in providing access to a wide range of medications, with minimal patient benefit. Additionally, the various proposals to implement government price controls across the larger health care system could

from http://besthealthnews.com/2019/11/mhn-statement-regarding-hr-3-the-houses-drug-pricing-package/?utm_source=rss&utm_medium=rss&utm_campaign=mhn-statement-regarding-hr-3-the-houses-drug-pricing-package

from
https://healthnews010.tumblr.com/post/189075590248